CHP Merger today announced that it will allow shareholders who redeemed stock ahead of Wednesday’s deadline extension vote may reverse their decision and receive 3.33 cents a share for each month of the extension period up to a maximum of 20 cents a share.
The SPAC wants to extend its merger deadline from this Friday until May 26.
CHP is in a pending merger with Accelus, a developer of minimally invasive spine surgery. The deal was announced a week ago today. Read more.
